Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bio-Rad Laboratories, Inc.    BIO

BIO-RAD LABORATORIES, INC.

(BIO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nyse
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
554.98(c) 516.56(c) 523.23(c) 535.07(c) 538.5(c) Last
247 953 872 566 302 615 274 360 657 906 Volume
-2.63% -6.92% +1.29% +2.26% +0.64% Change
More quotes
Financials (USD)
Sales 2020 2 430 M - -
Net income 2020 3 087 M - -
Net Debt 2020 - - -
P/E ratio 2020 5,26x
Yield 2020 -
Sales 2021 2 484 M - -
Net income 2021 358 M - -
Net Debt 2021 - - -
P/E ratio 2021 45,4x
Yield 2021 -
Capitalization 16 074 M 16 074 M -
Capi. / Sales 2020 6,62x
Capi. / Sales 2021 6,47x
Nbr of Employees 8 120
Free-Float 70,9%
More Financials
Company
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and... 
More about the company
Notations Surperformance© of Bio-Rad Laboratories, Inc.
Trading Rating : - Investor Rating :
More Ratings
All news about BIO-RAD LABORATORIES, INC.
10/30BIO RAD LABORATORIES : Management's Discussion and Analysis of Financial Conditi..
AQ
10/29BIO RAD LABORATORIES : Rad Reports Third-Quarter 2020 Financial Results
PU
10/29BIO-RAD LABORATORIES, INC. : Results of Operations and Financial Condition, Fina..
AQ
10/29BIO-RAD : 3Q Earnings Snapshot
AQ
10/29BIO RAD LABORATORIES : Rad Reports Third-Quarter 2020 Financial Results
BU
10/19BIO RAD LABORATORIES : Rad to Report Third-Quarter 2020 Financial Results, Thurs..
BU
08/14Growing R&D Activities to Push the Global Protein Expression Market to Garner..
AQ
08/13BIO RAD LABORATORIES : Prosecution History Estoppel And Claim Vitiation Not Enou..
AQ
08/04BIO RAD LABORATORIES : The United States Court of Appeals for the Federal Circui..
BU
07/31BIO RAD LABORATORIES : Management's Discussion and Analysis of Financial Conditi..
AQ
07/30BIO-RAD LABORATORIES, INC. : Results of Operations and Financial Condition, Othe..
AQ
07/30BIO-RAD : 2Q Earnings Snapshot
AQ
07/30BIO RAD LABORATORIES : Rad Reports Second-Quarter 2020 Financial Results
BU
07/15BIO RAD LABORATORIES : Rad to Report Second-Quarter 2020 Financial Results, Thur..
BU
06/15GLOBAL MARKETS LIVE: easyJet, AT&T, Warner Bros…
More news
News in other languages on BIO-RAD LABORATORIES, INC.
06/15L'ombre d'un doute
06/15EN DIRECT DES MARCHES : Peugeot, Orange, Verallia, Solocal, Valneva, easyJet,..
06/02AKTIE IM FOKUS : Sartorius können Rekordhoch nicht verteidigen - Verluste
2019JPMorgan startet Sartorius mit 'Overweight' - Ziel 200 Euro
2019STOCK MARKET PARIS : Paris attend des clarifications
More news
Chart BIO-RAD LABORATORIES, INC.
Duration : Period :
Bio-Rad Laboratories, Inc. Technical Analysis Chart | BIO | US0905722072 | MarketScreener
Technical analysis trends BIO-RAD LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 592,50 $
Last Close Price 538,50 $
Spread / Highest target 25,3%
Spread / Average Target 10,0%
Spread / Lowest Target -28,5%
EPS Revisions
Managers
NameTitle
Norman D. Schwartz Chairman, President & Chief Executive Officer
Andrew J. Last Chief Operating Officer & Executive Vice President
Ilan Daskal Chief Financial Officer & Executive Vice President
Alice N. Schwartz Director
Jeffrey L. Edwards Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIO-RAD LABORATORIES, INC.45.53%16 074
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858